ImmuCell Corporation Stock News

ImmuCell Corporation (NASDAQ:ICCC ) Q1 2022 Earnings Conference Call May 13, 2022 9:00 AM ET Company Participants Joe Diaz - Lytham Partners, IR Michael Brigham - President and CEO Joseph Crabb - Form

Q1 2022 Product Sales Increased 46% over Q1 2021 Q1 2022 Product Sales Increased 46% over Q1 2021

Conference Call Scheduled for Friday, May 13, 2022 at 9:00 AM ET Conference Call Scheduled for Friday, May 13, 2022 at 9:00 AM ET

PORTLAND, Maine, May 05, 2022 (GLOBE NEWSWIRE) -- Certain immaterial corrections have been made to the second and fifth paragraphs.

PORTLAND, Maine, May 05, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets

PORTLAND, Maine, April 11, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and market

The IUL marketing insurance companies sell the agents, who in turn, sell the public, doesn’t sit well with me.

A look at the key differences between indexed univeral life insurance and whole life insurance and some tips for individuals trying to decide between them.

ImmuCell Corp (ICCC) CEO Michael Brigham Q4 2021 Results Earnings Call Transcript

Annual Product Sales for 2021 Increased 25% over 2020 Annual Product Sales for 2021 Increased 25% over 2020

Conference Call Scheduled for Wednesday, February 23, 2022 at 9:00 AM ET Conference Call Scheduled for Wednesday, February 23, 2022 at 9:00 AM ET

Conference Call Scheduled for Wednesday, February 23, 2022 at 9:00 AM ET Conference Call Scheduled for Wednesday, February 23, 2022 at 9:00 AM ET

PORTLAND, Maine, Jan. 05, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets

ImmuCell (NASDAQ:ICCC) and Aspira Womens Health (NASDAQ:AWH) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, institutional ownership, valuation, earnings and analyst recommendations. Analyst Recommendations This is a breakdown of recent ratings and price targets for ImmuCell and []